These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7571921)

  • 21. Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates.
    Aldenkamp AP; Rentmeester T; Hulsman J; Majoie M; Doelman J; Diepman L; Schellekens A; Franken M; Olling M
    Eur J Clin Pharmacol; 1998 Apr; 54(2):185-92. PubMed ID: 9626926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetic modelling of carbamazepine by using the iterative Bayesian (IT2B) and the nonparametric EM (NPEM) algorithms: implications for dosage.
    Bondareva IB; Sokolov AV; Tischenkova IF; Jelliffe RW
    J Clin Pharm Ther; 2001 Jun; 26(3):213-23. PubMed ID: 11422606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.
    Markoula S; Teotonio R; Ratnaraj N; Duncan JS; Sander JW; Patsalos PN
    Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The optimization of epilepsy therapy with finlepsin].
    Gromov SA; Khorshev SK; Mikhaĭlov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(9):32-5. PubMed ID: 11026133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does carbamazepine have a narrow therapeutic plasma concentration range?
    Bialer M; Levy RH; Perucca E
    Ther Drug Monit; 1998 Feb; 20(1):56-9. PubMed ID: 9485555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
    Jankovic SM; Jovanovic D; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats.
    Reeta KH; Mehla J; Pahuja M; Gupta YK
    Pharmacol Biochem Behav; 2011 Sep; 99(3):399-407. PubMed ID: 21641922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy.
    Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbamazepine and lamotrigine plasma concentrations in epileptic patients during optimising therapy.
    Krasniqi S; Neziri B; Islami H; Bauer S
    Med Arh; 2010; 64(2):80-3. PubMed ID: 20514770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative evaluation of pharmacokinetics of conventional and slow-release carbamazepine formulation in newly treated patients of epilepsy: a random evaluation.
    Nag D; Garg RK; Agarwal A
    J Assoc Physicians India; 1998 Feb; 46(2):185-8. PubMed ID: 11273108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Slow carbamazepine clearance in a nonadherent Malay woman with epilepsy and thyrotoxicosis.
    Yeap LL; Lim KS; Ng CC; Hui-Ping Khor A; Lo YL
    Ther Drug Monit; 2014 Feb; 36(1):3-9. PubMed ID: 24342894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic simulation of fatal carbamazepine intoxication in 23-month old child following phenytoin discontinuation.
    Venci JV; Rowcliffe MM; Wollenberg L; Rainka MM; Gengo FM
    Forensic Sci Med Pathol; 2013 Mar; 9(1):73-6. PubMed ID: 22915321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric carbamazepine suspension overdose-clinical manifestations and toxicokinetics.
    Perez A; Wiley JF
    Pediatr Emerg Care; 2005 Apr; 21(4):252-4. PubMed ID: 15824685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diurnal fluctuations in plasma carbamazepine level in children with epilepsy].
    Losiowski Z; Prokopczyk J; Zimak J; Bielicka J
    Neurol Neurochir Pol; 1988; 22(3):195-200. PubMed ID: 3221956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy.
    Ahmed GF; Brundage RC; Marino SE; Cloyd JC; Leppik IE; Pennell PB; Ramsay RE; Birnbaum AK
    J Clin Pharmacol; 2013 Mar; 53(3):276-84. PubMed ID: 23408495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian estimation of six different sets of carbamazepine pharmacokinetic parameters in Egyptian adult epileptic patients.
    EL Desoky ES; Kandil MR
    Pharmacol Res; 2002 Feb; 45(2):113-8. PubMed ID: 11846622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum alkaline phosphatase in epilepsy: effect of age and treatment.
    Rawat C; Kukal S; Kushwaha S; Agarwal R; Sharma S; Srivastava AK; Kukreti R
    Br J Biomed Sci; 2020 Jan; 77(1):44-47. PubMed ID: 31483219
    [No Abstract]   [Full Text] [Related]  

  • 39. Replacing carbamazepine slow-release tablets with carbamazepine suppositories: a pharmacokinetic and clinical study in children with epilepsy.
    Arvidsson J; Nilsson HL; Sandstedt P; Steinwall G; Tonnby B; Flesch G
    J Child Neurol; 1995 Mar; 10(2):114-7. PubMed ID: 7782600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of combination therapy on the plasma concentrations of traditional antiepileptics: a retrospective study.
    Sirmagul B; Atli O; Ilgin S
    Hum Exp Toxicol; 2012 Oct; 31(10):971-80. PubMed ID: 22588177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.